DINUTUXIMAB BETA for Neuroblastoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 141 adverse event reports in the FDA FAERS database where DINUTUXIMAB BETA was used for Neuroblastoma.
Most Reported Side Effects for DINUTUXIMAB BETA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 82 | 52.2% | 22 | 7 |
| Pyrexia | 57 | 36.3% | 2 | 7 |
| Pain | 46 | 29.3% | 3 | 3 |
| Death | 20 | 12.7% | 20 | 0 |
| Neoplasm progression | 20 | 12.7% | 14 | 0 |
| Device related bacteraemia | 17 | 10.8% | 0 | 0 |
| Device related infection | 16 | 10.2% | 0 | 0 |
| Diarrhoea | 11 | 7.0% | 1 | 1 |
| Therapy partial responder | 11 | 7.0% | 6 | 0 |
| Cough | 10 | 6.4% | 0 | 0 |
| Rash | 10 | 6.4% | 1 | 0 |
| Cholestasis | 7 | 4.5% | 0 | 7 |
| Pruritus | 7 | 4.5% | 1 | 0 |
| Acute myeloid leukaemia | 6 | 3.8% | 0 | 0 |
| Alanine aminotransferase abnormal | 6 | 3.8% | 0 | 0 |
Other Indications for DINUTUXIMAB BETA
Metastases to bone marrow (27)
Bone cancer metastatic (26)
Neuroblastoma recurrent (13)
Metastatic lymphoma (7)
Other Drugs Used for Neuroblastoma
CYCLOPHOSPHAMIDE (1,109)
ETOPOSIDE (1,061)
DOXORUBICIN (725)
CARBOPLATIN (671)
VINCRISTINE (668)
CISPLATIN (633)
MELPHALAN (495)
TOPOTECAN (443)
DINUTUXIMAB (354)
BUSULFAN (252)